Published in J Phys Chem C Nanomater Interfaces on April 06, 2007
Photoacoustic imaging and temperature measurement for photothermal cancer therapy. J Biomed Opt (2008) 2.93
Nanoparticle-based theranostic agents. Adv Drug Deliv Rev (2010) 2.86
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34
Multifunctional nanoparticles as coupled contrast agents. Nat Commun (2010) 2.23
Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res (2009) 2.22
Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano (2010) 1.78
Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res (2010) 1.60
Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res (2011) 1.48
Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev (2010) 1.29
Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications. ACS Nano (2010) 1.19
Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine (Lond) (2012) 1.17
Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and t2* magnetic resonance imaging. Invest Radiol (2011) 1.07
Nonporous Silica Nanoparticles for Nanomedicine Application. Nano Today (2013) 1.04
Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy. Mater Res Bull (2009) 1.04
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One (2011) 1.02
Multifunctional Particles: Magnetic Nanocrystals and Gold Nanorods Coated with Fluorescent Dye-Doped Silica Shells. J Solid State Chem (2008) 1.00
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol (2011) 0.98
"Smart" diblock copolymers as templates for magnetic-core gold-shell nanoparticle synthesis. Nano Lett (2010) 0.96
Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells. ACS Nano (2011) 0.94
Fluorinated graphene oxide; a new multimodal material for biological applications. Adv Mater (2013) 0.93
Limitations on the optical tunability of small diameter gold nanoshells. Langmuir (2009) 0.93
Autoregressive moving average modeling for spectral parameter estimation from a multigradient echo chemical shift acquisition. Med Phys (2009) 0.88
Dual-modality fiber-based OCT-TPL imaging system for simultaneous microstructural and molecular analysis of atherosclerotic plaques. Biomed Opt Express (2015) 0.81
Two-photon luminescence properties of gold nanorods. Biomed Opt Express (2013) 0.81
Research perspectives: gold nanoparticles in cancer theranostics. Quant Imaging Med Surg (2013) 0.80
Characterizing the localized surface plasmon resonance behaviors of Au nanorings and tracking their diffusion in bio-tissue with optical coherence tomography. Biomed Opt Express (2010) 0.79
Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy. Theranostics (2016) 0.78
The Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature Review. J Lasers Med Sci (2016) 0.75
Size- and Shape-Controlled Synthesis and Properties of Magnetic-Plasmonic Core-Shell Nanoparticles. J Phys Chem C Nanomater Interfaces (2016) 0.75
Synthesis and Properties of Magnetic-Optical Core-Shell Nanoparticles. RSC Adv (2017) 0.75
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett (2004) 7.12
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol (2001) 4.84
Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett (2005) 4.70
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res (2003) 4.22
Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat (2004) 4.06
Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm (2005) 3.08
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol (2002) 2.06
Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy (2004) 1.52
Nanotechnology for molecular imaging and targeted therapy. Circulation (2003) 1.38
Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol (2000) 1.27
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging (2001) 1.18
The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J Nanobiotechnology (2006) 1.12
Magnetite-containing spherical silica nanoparticles for biocatalysis and bioseparations. Anal Chem (2004) 1.08
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol (2006) 1.03
Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun (2005) 0.98